dacarbazine has been researched along with Carcinoma, Transitional Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donovski, L; Kumanov, Kh; Ormanov, I; Panchev, P; Tsvetkov, M | 1 |
Kumanov, Kh; Ormanov, I; Tsvetkov, M | 1 |
2 other study(ies) available for dacarbazine and Carcinoma, Transitional Cell
Article | Year |
---|---|
[Cases of the regression of advanced bladder tumors (T2-T4) after the use of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Epirubicin; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms; Vinblastine | 1989 |